menu search

KRON / Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 23.8% in 4 Weeks

Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 23.8% in 4 Weeks
Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. Read More
Posted: Nov 22 2022, 11:17
Author Name: Zacks Investment Research
Views: 082175

KRON News  

Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 10, 2023

Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue Estimates

Kronos Bio, Inc. (KRON) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to los more_horizontal

Kronos Bio's stock rallies after announcing drug-discovery deal with Roche

By Market Watch
January 9, 2023

Kronos Bio's stock rallies after announcing drug-discovery deal with Roche

Shares of Kronos Bio Inc. KRON, +2.38% jumped 25% in premarket trading on Monday after the company announced a development deal with Roche Holding's R more_horizontal

Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 31% in 4 Weeks

By Zacks Investment Research
December 12, 2022

Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 31% in 4 Weeks

Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal

Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 23.8% in 4 Weeks

By Zacks Investment Research
November 22, 2022

Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 23.8% in 4 Weeks

Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal

Kronos Bio Announces Participation in Upcoming Investor Conferences

By GlobeNewsWire
June 1, 2022

Kronos Bio Announces Participation in Upcoming Investor Conferences

SAN MATEO, Calif. and CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the liv more_horizontal


Search within

Pages Search Results: